Arena Withdrawing Obesity Drug Regulatory Application in Europe

Arena Pharmaceuticals Inc., the maker of the weight-loss drug Belviq, said it is withdrawing its application to gain regulatory approval in Europe for the obesity medicine.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.